Simcere Pharmaceutical Group Filed 2012 Annual Report on Form 20-F
Source: PRNewswire View: 253 Date: 2013-04-27

Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, announced today that the Company filed its annual report on Form 20-F for the year ended December 31, 2012 with the Securities and Exchange Commission on April 26, 2013, U.S. Eastern Time. The annual report can be accessed on the Company’s investor relations website at http://ir.simcere.com. The Company will provide a hard copy of the annual report containing its audited financial statements for the year ended December 31, 2012, free of charge, to its shareholders and ADS holders upon request.

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group ("Simcere") (NYSE: SCR) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, cardiovascular disease, infectious diseases and pain. For more information about Simcere Pharmaceutical Group, please visit www.simcere.com.

SOURCE Simcere Pharmaceutical Group

 

RELATED LINKS
http://www.simcere.com
http://ir.simcere.com

Devott Publications
The Selection of the TOP Global Outsourcing Destinations – China TOP 15 (TGOD China TOP 15) Ended and Its Rankings and Research Reports are Now Available Worldwide